« Back
Home /
Bosentan (hydrate)

Bosentan (hydrate)

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	1 g
Item no.	HY-A0013A-1g
Targets	Endothelin Receptor
CASRN	157212-55-0
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	569.63
Clinical_Information	Launched
Manufacturers Research_Area	Cardiovascular Disease; Endocrinology; Cancer
Solubility	DMSO : ≥ 100 mg/mL\|Ethanol : 50 mg/mL (ultrasonic)\|H2O : < 0.1 mg/mL
Manufacturers Target	Endothelin Receptor
Pathway	GPCR/G Protein
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-A0013A-1g-safety-datasheet.pdf